000 01494 a2200397 4500
005 20250516135454.0
264 0 _c20130312
008 201303s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD008300.pub2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCuello-García, Carlos A
245 0 0 _aTreating BCG-induced disease in children.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cJan 2013
300 _aCD008300 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aAbscess
_xmicrobiology
650 0 4 _aAdjuvants, Immunologic
_xadverse effects
650 0 4 _aAntibiotics, Antitubercular
_xtherapeutic use
650 0 4 _aBCG Vaccine
_xadverse effects
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aErythromycin
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aIsoniazid
_xtherapeutic use
650 0 4 _aLymphadenitis
_xmicrobiology
650 0 4 _aMycobacterium bovis
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRifampin
_xtherapeutic use
650 0 4 _aSuction
_xmethods
700 1 _aPérez-Gaxiola, Giordano
700 1 _aJiménez Gutiérrez, Carlos
773 0 _tThe Cochrane database of systematic reviews
_gno. 1
_gp. CD008300
856 4 0 _uhttps://doi.org/10.1002/14651858.CD008300.pub2
_zAvailable from publisher's website
999 _c22534351
_d22534351